Equine viral arteritis (EVA) is a cause of abortion and neonatal deaths. In France, surveillance of EVA is based mostly on serological testing of all or part of the breeding horses, depending on the studbooks' regulations. Hence, EVA incidence is not precisely known in the overall breeding population. The first objective of this study was to estimate the number of EVA cases and outbreaks detected by the equine breeding stock surveillance between 2006 and 2013 in France, by establishing suitable rules for identification of seroconversion. The second objective was to assess the surveillance sensitivity, after having estimated the total number of outbreaks that occurred in breeding stock during this period using a capture-recapture model. Data from breeding mares which exhibited at least one positive result in serology using viral neutralization test between 2006 and 2013 were used for analysis (n¼1,645). Data consisted of the annual antibody titers and the location of the mares (towns). Seroconversion was defined as a change in antibody titer from negative to at least 32 or a three-fold increase. The number of seroconversions was counted for each town and modeled using an unilist zero-truncated binomial (ZTB) capture-recapture model with R software. The binomial denominator was the number of horses tested in each infected town. From 2006 to 2013, 239 cases of seroconversion located in 177 towns (outbreaks) were identified. During this period, the number of outbreaks in breeding stock was estimated at 1,482 (CI 95% 1,257-1,815) using the ZTB model. Consequently, it is estimated that over 1,000 outbreaks were not detected and the surveillance sensitivity at the town level was estimated around 12% (CI 95% 10%-14%). This study revealed a significant number of outbreaks in breeding stock. However, the surveillance sensitivity seems underestimated, especially due to lack of details related to the holdings, such as the number of at risk contacts or their precise address (the holdings list was not available and several holdings may be located within the same town). Nevertheless, the sensitivity could certainly be improved by including more breeding horses in the active surveillance. This study is the first in France to estimate the EVA incidence in breeding stock and to assess quantitatively the surveillance sensitivity. Moreover, the rules for identification of seroconversion defined in this study may be used to analyze other EVA surveillance datasets based on serology, such as testing before sales or international trade, and even compulsory or voluntary passive surveillance. Such rules, adjusted to the local environment, could conceivably be applied in other countries with EVA surveillance programs. 
